The required controlled access program [3] is now in place in Finland, enabling private clinics such as Terveystalo Ruoholahti, where the first patient was treated, to help patients with early ...
18h
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”
Viehbacher, “Biogen”) announced today that LEQEMBI ® IQLIK™, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer’s disease (AD) has been selected by ...
France's perfect record in their World Cup qualifying campaign ended as they were held to a 2-2 draw away to Iceland who got ...
Mineral Resource Estimate Confirms Pitfield's World Dominant Titanium Discovery Empire Metals Ltd., the AIM-quoted and OTCQX-traded exploration and development company, is pleased to report a maiden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback